|
US4196265A
(en)
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4978503A
(en)
|
1984-06-13 |
1990-12-18 |
Ares-Serono Research & Development Limited Partnership |
Devices for use in chemical test procedures
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5356817A
(en)
|
1988-06-09 |
1994-10-18 |
Yale University |
Methods for detecting the onset, progression and regression of gynecologic cancers
|
|
FI903489A7
(fi)
|
1988-11-11 |
1990-07-10 |
Medical Res Council |
Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
ES2063348T3
(es)
|
1989-04-11 |
1995-01-01 |
Ars Holding 89 Nv |
Vehiculo de ensayo multianalitico.
|
|
US6291158B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
AU3691093A
(en)
|
1992-04-14 |
1993-10-21 |
Hybritech Incorporated |
Methods of inhibiting the growth of multidrug resistant tumors
|
|
DE69334275D1
(de)
|
1992-08-21 |
2009-05-20 |
Univ Bruxelles |
Immunoglobuline ohne Leichtkette
|
|
CA2145278C
(en)
|
1992-09-25 |
2009-03-10 |
Commonwealth Scientific And Industrial Research Organisation |
Target binding polypeptide
|
|
CA2126967A1
(en)
|
1992-11-04 |
1994-05-11 |
Anna M. Wu |
Novel antibody construct
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
AUPO591797A0
(en)
|
1997-03-27 |
1997-04-24 |
Commonwealth Scientific And Industrial Research Organisation |
High avidity polyvalent and polyspecific reagents
|
|
US6113898A
(en)
|
1995-06-07 |
2000-09-05 |
Idec Pharmaceuticals Corporation |
Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
|
|
EP0859841B1
(en)
|
1995-08-18 |
2002-06-19 |
MorphoSys AG |
Protein/(poly)peptide libraries
|
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
|
ATE374248T1
(de)
|
1996-06-27 |
2007-10-15 |
Vlaams Interuniv Inst Biotech |
Antikörpermoleküle, die spezifisch mit dem aktiven zentrum oder dem aktiven spalt eines zielmoleküls interagieren
|
|
AUPP221098A0
(en)
|
1998-03-06 |
1998-04-02 |
Diatech Pty Ltd |
V-like domain binding molecules
|
|
ATE370961T1
(de)
|
1998-05-06 |
2007-09-15 |
Genentech Inc |
Reinigung von antikörpern durch ionenaustauschchromatographie
|
|
US6562622B1
(en)
|
1998-05-08 |
2003-05-13 |
Diatech Pty, Ltd |
Continuous in vitro evolution
|
|
US6306610B1
(en)
|
1998-09-18 |
2001-10-23 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
AU776910B2
(en)
|
1998-12-08 |
2004-09-23 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Modifying protein immunogenicity
|
|
US7270969B2
(en)
|
1999-05-05 |
2007-09-18 |
Phylogica Limited |
Methods of constructing and screening diverse expression libraries
|
|
US7229619B1
(en)
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
JP4369662B2
(ja)
|
2001-04-26 |
2009-11-25 |
アビディア インコーポレイテッド |
単量体ドメインのコンビナトリアルライブラリー
|
|
AU2002368077B2
(en)
|
2001-07-12 |
2010-03-04 |
Jefferson Foote |
Super humanized antibodies
|
|
US7964194B2
(en)
|
2002-11-15 |
2011-06-21 |
Morehouse School Of Medicine |
Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation
|
|
US8563476B2
(en)
|
2002-11-15 |
2013-10-22 |
Morehouse School Of Medicine |
Anti-CXCL9, anti-CXCL10, anti-CXCL11, anti-CXCL13, anti-CXCR3 and anti-CXCR5 agents for inflammatory disorders
|
|
US20120135415A1
(en)
|
2002-11-15 |
2012-05-31 |
Morehouse School Of Medicine |
Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies
|
|
AU2004245038A1
(en)
|
2003-06-02 |
2004-12-16 |
Alexion Pharmaceuticals, Inc. |
De-immunized anti-CD3 antibody
|
|
CA2531238C
(en)
|
2003-07-04 |
2015-02-24 |
Affibody Ab |
Polypeptides having binding affinity for her2
|
|
BRPI0417302A
(pt)
|
2003-12-05 |
2007-03-06 |
Compound Therapeutics Inc |
inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
|
|
JP4958555B2
(ja)
|
2004-09-22 |
2012-06-20 |
協和発酵キリン株式会社 |
安定化されたヒトＩｇＧ４抗体
|
|
US20060263367A1
(en)
|
2005-05-23 |
2006-11-23 |
Fey Georg H |
Bispecific antibody devoid of Fc region and method of treatment using same
|
|
WO2007019620A1
(en)
|
2005-08-15 |
2007-02-22 |
Arana Therapeutics Limited |
Engineered antibodies with new world primate framework regions
|
|
EP1777523A1
(en)
|
2005-10-19 |
2007-04-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
|
|
NZ544432A
(en)
|
2005-12-23 |
2009-07-31 |
Pacific Edge Biotechnology Ltd |
Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
|
|
US8124332B2
(en)
*
|
2006-09-14 |
2012-02-28 |
Institut Pasteur |
Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections
|
|
AU2007350900A1
(en)
|
2007-04-05 |
2008-10-16 |
Source Precision Medicine, Inc. |
Gene expression profiling for identification, monitoring and treatment of ovarian cancer
|
|
CN101971033A
(zh)
|
2007-06-04 |
2011-02-09 |
戴诺普雷克斯公司 |
用于结直肠癌的生物标志物组合
|
|
GB0806812D0
(en)
*
|
2008-04-15 |
2008-05-14 |
Univ Leuven Kath |
Citrullinated cytokines
|
|
JP5734201B2
(ja)
|
2008-12-19 |
2015-06-17 |
マクロジェニクス，インコーポレーテッド |
共有結合型ダイアボディ及びその使用
|
|
JP2012515556A
(ja)
|
2009-01-23 |
2012-07-12 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
低下したエフェクタ機能を有する安定化Ｆｃポリペプチドおよび使用方法
|
|
EP2367000A1
(en)
|
2010-03-04 |
2011-09-21 |
Charité Universitätsmedizin Berlin |
High throughput analysis of T-cell receptor repertoires
|
|
US9617329B2
(en)
|
2010-10-01 |
2017-04-11 |
Csl Limited |
Method of cloning nucleic acid
|
|
JP2014505239A
(ja)
|
2010-12-14 |
2014-02-27 |
モアハウス スクール オブ メディスン |
癌の治療または検出のための抗ｃｘｃｌ１３および抗ｃｘｃｒ５抗体の使用
|
|
CN103582815A
(zh)
*
|
2011-02-24 |
2014-02-12 |
佛米利昂公司 |
用于卵巢癌的生物标志物组、诊断方法和测试试剂盒
|
|
US10308980B2
(en)
|
2011-11-04 |
2019-06-04 |
Oslo Universitetssykehus Hf |
Methods and biomarkers for analysis of colorectal cancer
|
|
KR101452865B1
(ko)
|
2012-09-17 |
2014-10-21 |
서울대학교산학협력단 |
신규한 ｉｐ－１０ 에피토프 및 이에 대한 항체
|
|
DK2914739T3
(da)
|
2012-11-05 |
2017-11-27 |
Novigenix Sa |
Kombinationer af biomarkører for kolorektale tumorer
|
|
EP3060250A1
(en)
*
|
2013-10-22 |
2016-08-31 |
NovImmune SA |
Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of tlr4 ligands and other biomarkers
|
|
EP3073268A1
(en)
|
2015-03-27 |
2016-09-28 |
Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts |
Biomarker panel for diagnosing cancer
|
|
US10556948B2
(en)
|
2015-11-30 |
2020-02-11 |
Bristol-Myers Squibb Company |
IP-10 antibodies and their uses
|
|
CN106868012B
(zh)
*
|
2015-12-14 |
2020-08-18 |
广西医科大学 |
靶向肿瘤血管内皮细胞的ip10单链抗体及制备方法
|
|
WO2020109570A1
(en)
|
2018-11-30 |
2020-06-04 |
Gbg Forschungs Gmbh |
Method for predicting the response to cancer immunotherapy in cancer patients
|
|
WO2020124083A1
(en)
|
2018-12-14 |
2020-06-18 |
The Brigham And Women's Hospital, Inc. |
Biomarker panels for on-treatment prediction of response to immuno-oncology drugs
|
|
US20220381791A1
(en)
|
2019-10-01 |
2022-12-01 |
bioMérieux |
Method for determining an individual ability to respond to a stimulus
|
|
US20210347847A1
(en)
|
2020-05-11 |
2021-11-11 |
The Broad Institute, Inc. |
Therapeutic targeting of malignant cells using tumor markers
|